Cranex Limited is a leading provider of cranial and facial implants and devices. The company was founded in 2006 by Dr. William P. Adams and Dr. David A. Reinstein, two highly respected and experienced craniofacial surgeons. Cranex has a state-of-the-art manufacturing facility in New Jersey, USA and a sales and marketing office in London, UK. The company’s products are sold in over 50 countries worldwide.
Cranex’s mission is to improve the quality of life for patients with craniofacial anomalies through the development and commercialization of innovative, safe and effective implants and devices. The company’s products are designed to restore function and improve aesthetics for patients with craniofacial conditions such as cleft palate, craniofacial microsomia, craniosynostosis and trauma.
Cranex employs a team of highly skilled professionals, including engineers, manufacturing specialists, quality assurance experts and sales and marketing professionals. The company’s products are backed by a strong research and development program. Cranex is committed to providing the highest level of customer service and support.
Cranex is a publicly traded company listed on the Nasdaq Stock Market (symbol: CRNX). The company’s website is www.cranex.com.